The smooth muscle pharmacology of maximakinin, a receptor-selective, bradykinin-related nonadecapeptide from the venom of the Chinese toad, Bombina maxima

Regulatory Peptides

Volumn 121, Issue 1-3, 2004, Pages 65-72

  O'Rourke, Martin ^a   Chen, Tianbao ^a,b   Hirst, David G ^a   Rao, Pingfan ^b   Shaw, Chris ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b FUZHOU UNIVERSITY   (China)

Author keywords

Amphibian; Bradykinin; Peptides; Receptor

Indexed keywords

ASPARTYLLEUCYLPROLYLLYSYLISOLEUCYLASPARAGINYLARGINYLLYSYLGLYCYLPROLYLARGINY LPROLYLPROLYLGLYCYLPHENYLALANYLSERYLPROLYLPHENYLALANYLARGININE; BRADYKININ; BRADYKININ RECEPTOR; LIGAND; MAXIMAKININ; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; VENOM;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; FEMALE; INTESTINE MUSCLE; MALE; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN SECRETION; SMOOTH MUSCLE; TOAD;

AMINO ACID SEQUENCE; AMPHIBIAN VENOMS; ANIMALS; ANURA; ARTERIES; BIOLOGICAL ASSAY; BRADYKININ; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; RATS; RECEPTORS, BRADYKININ; SUBSTRATE SPECIFICITY; TIME FACTORS; VENOMS;

AMPHIBIA; ANURA; BOMBINA; BOMBINA MAXIMA; MAMMALIA; VERTEBRATA;

EID: 3142648792     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.04.007     Document Type: Article

References (19)

1. Erspamer V. Bioactive secretions of the integument. Heatwole H., Barthalmus G.T. Amphibian Biology, Vol. 1. The Integument. 1994;178-350 Surrey Beatty & Sons, Chipping Norton. Chap. 9
2. Lazarus L.H., Atilla M. The toad, ugly and venomous, wears yet a precious jewel in his skin. Prog. Neurobiol. 41:1993;473-507
3. Bevins C.L., Zasloff M. Peptides from frog skin. Annu. Rev. Biochem. 59:1990;395-414
4. Chen T., Orr D.F., Bjourson A.J., McClean S., O'Rourke M., Hirst D.G., et al. Novel bradykinins and their precursor cDNAs from European yellow-bellied toad (Bombina variegata) skin. Eur. J. Biochem. 269:2002;4693-4700
5. Chen T., Orr D.F., Bjourson A.J., McClean S., O'Rourke M., Hirst D.G., et al. Bradykinins and their precursor cDNAs from the skin of the Fire-Bellied Toad (Bombina orientalis). Peptides. 23:2002;1547-1555
6. Clarke B.T. The natural history of amphibian skin secretions, their normal functioning and potential medical applications. Biol. Rev. Camb. Philos. Soc. 72:1997;365-379
7. Chen T., Bjourson A.J., McClean S., Orr D.F., O'Kane E.J., Rao P., et al. Cloning of maximakinin precursor cDNAs from Chinese toad, Bombina maxima, venom. Peptides. 24:2003;853-861
8. Conlon J.M., Aronsson U. Multiple bradykinin-related peptides in the skin of the frog, Rana temporaria. Peptides. 18:1997;361-365
9. 6-bradykinin and its analogue peptide, ranakinin R. Chem. Pharm. Bull. (Tokyo). 27:1979;486-491
10. Nakajima T. Occurrence of new active peptides on smooth muscle and bradykinin in the skin of Rana nigromaculata Hallowell. Chem. Pharm. Bull. (Tokyo). 16:1968;769-774
11. Anastasi A., Bertaccini G., Erspamer V. Pharmacological data on phyllokinin (braykinyl-isoleucyl-tyrosine-0-sulphate) and bradykinyl-isoleucyl- tyrosine. Br. J. Pharmacol. 27:1966;479-485
12. Yasuhara T., Hira M., Nakajima T., Yanaihara N., Yanaihara C. Active peptides on smooth muscle in the skin of Bombina orientalis Boulenger and characterization of a new bradykinin analog. Chem. Pharm. Bull. (Tokyo). 21:1973;138-139
13. Hirst D.G., Kennovin G.D., Flitney F.W. The radiosensitizer nicotinamide inhibits arterial vasoconstriction. Br. J. Radiol. 67:1994;795-799
14. Hock F.J., Wirth K., Albus U., Linz W., Gerhards H.J., Wiemer G., et al. HOE140, a new potent and long-acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol. 102:1991;769-773
15. Drouin J.N., Gaudreau P., St-Pierre S., Regoli D. Biological activities of kinins modified at the N- or at the C-terminal end. Can. J. Physiol. Pharmacol. 57:1979;1018-1023
16. Bertaccini G. Active polypeptides of nonmammalian origin. Pharmacol. Rev. 28:1976;127-177
17. Regoli D., Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46
18. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens and kinases. Pharmacol. Rev. 44:1992;1-80
19. Parkes D., Jodka C., Smith P., Nayak S., Rinehart L., Gingerich R., et al. Pharmacokinetic actions of exendin-4 in the rat: comparison with glucagon-like peptide-1. Drug Dev. Res. 53:2001;260-267